Kuhnil to complete health registration of Omacor for hyperlipidemia.

Published: 2006-01-11 06:59:00
Updated: 2006-01-11 06:59:00
Kuhnil announced that the KFDA registration of Omacor (omega-3 fatty acid ethylester) was completed for the treatment of hyperlipidemia.

Omacor was originally developed by Pronova in Norway, approved very recently by the U. S. FDA as a prescription drug for the treatment of hyperlimpidemia an...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.